Rangeley Capital »

Lava Therapeutics Nv shares owned by Rangeley Capital

Quarter-by-quarter ownership of Lava Therapeutics Nv (LVTX) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Lava Therapeutics Nv

Tip: Access up to 7 years of quarterly data

All positions including Lava Therapeutics Nv held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lava Therapeutics Nv by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $257k 165k 1.56
2025-06-30 $36k 27k 1.32

More positions owned by Rangeley Capital

Delek Us Holdings (DK)
Calumet (CLMT)
Arvinas Ord (ARVN)
Prothena Corp SHS (PRTA)
Wideopenwest (WOW)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Yext (YEXT)
Keros Therapeutics (KROS)
Arbutus Biopharma (ABUS)
Seaport Entmt Group Common Stock (SEG)
Berto Acquisition Corp Ord Shs (TACO)
Charter Communications Inc N Cl A (CHTR)
Full House Resorts (FLL)
Surgery Partners (SGRY)
Core Scientific *w Exp 01/23/202 (CORZW)

View all positions for Rangeley Capital

Top funds holding Lava Therapeutics Nv

Shay Capital
Redmile Group
BML Capital Management
Sanofi
Merck & Co
Gts Securities
Rangeley Capital
Susquehanna International
Pnc Financial Services
Citadel Advisors
Royal Bank of Canada
Lepercq De Neuflize Asset Management
Equitec Proprietary Markets
JBF Capital
XTX Topco

View all funds holding Lava Therapeutics Nv